시장조사 보고서 : 세계의 겸상 적혈구 빈혈 치료제 시장예측 2021년-2026년

■ 영문 제목 : Global Sickle Cell Anemia Therapeutics Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02177 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 114 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 겸상 적혈구 빈혈 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (수혈, 약물 요법, 골수 이식)와 용도별 시장규모 (어린이, 성인) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 겸상 적혈구 빈혈 치료제 시장 점유율
- 지역별 겸상 적혈구 빈혈 치료제 시장규모
- 주요지역의 종류별 시장규모 (수혈, 약물 요법, 골수 이식)
- 주요지역의 용도별 시장규모 (어린이, 성인)
- 미주의 겸상 적혈구 빈혈 치료제 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 겸상 적혈구 빈혈 치료제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 겸상 적혈구 빈혈 치료제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 겸상 적혈구 빈혈 치료제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 겸상 적혈구 빈혈 치료제 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Emmaus Medical, Addmedica, Gamida Cell, GlycoMimetics, Pfizer, Novartis, Global Blood Therapeutics, Micelle BioPharma, Bluebird Bio, Prolong Pharmaceuticals, Modus Therapeutics, Sangamo Biosciences, Bioverativ, Imara, Ironwood Pharmaceuticals
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Sickle Cell Anemia Therapeutics will have significant change from previous year. By the most conservative estimates of global Sickle Cell Anemia Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2830.1 million in 2020. Over the next five years the Sickle Cell Anemia Therapeutics market will register a 16.3% CAGR in terms of revenue, the global market size will reach US$ 5175.1 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Sickle Cell Anemia Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Blood Transfusion
Pharmacotherapy
Bone Marrow Transplant

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Child
Adult

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Emmaus Medical
Addmedica
Gamida Cell
GlycoMimetics
Pfizer
Novartis
Global Blood Therapeutics
Micelle BioPharma
Bluebird Bio
Prolong Pharmaceuticals
Modus Therapeutics
Sangamo Biosciences
Bioverativ
Imara
Ironwood Pharmaceuticals

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sickle Cell Anemia Therapeutics Market Size 2016-2026
2.1.2 Sickle Cell Anemia Therapeutics Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Sickle Cell Anemia Therapeutics Segment by Type
2.2.1 Blood Transfusion
2.2.2 Blood Transfusion
2.2.3 Bone Marrow Transplant
2.3 Sickle Cell Anemia Therapeutics Market Size by Type
2.3.1 Global Sickle Cell Anemia Therapeutics Market Size CAGR by Type
2.3.2 Global Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2016-2021)
2.4 Sickle Cell Anemia Therapeutics Segment by Application
2.4.1 Child
2.4.2 Adult
2.5 Sickle Cell Anemia Therapeutics Market Size by Application
2.5.1 Global Sickle Cell Anemia Therapeutics Market Size CAGR by Application
2.5.2 Global Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2016-2021)

3 Sickle Cell Anemia Therapeutics Market Size by Players
3.1 Sickle Cell Anemia Therapeutics Market Size Market Share by Players
3.1.1 Global Sickle Cell Anemia Therapeutics Revenue by Players (2019-2021E)
3.1.2 Global Sickle Cell Anemia Therapeutics Revenue Market Share by Players (2019-2021E)
3.2 Global Sickle Cell Anemia Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Sickle Cell Anemia Therapeutics by Regions
4.1 Sickle Cell Anemia Therapeutics Market Size by Regions (2016-2021)
4.2 Americas Sickle Cell Anemia Therapeutics Market Size Growth (2016-2021)
4.3 APAC Sickle Cell Anemia Therapeutics Market Size Growth (2016-2021)
4.4 Europe Sickle Cell Anemia Therapeutics Market Size Growth (2016-2021)
4.5 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Growth (2016-2021)

5 Americas
5.1 Americas Sickle Cell Anemia Therapeutics Market Size by Country (2016-2021)
5.2 Americas Sickle Cell Anemia Therapeutics Market Size by Type (2016-2021)
5.3 Americas Sickle Cell Anemia Therapeutics Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Sickle Cell Anemia Therapeutics Market Size by Region (2016-2021)
6.2 APAC Sickle Cell Anemia Therapeutics Market Size by Type (2016-2021)
6.3 APAC Sickle Cell Anemia Therapeutics Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Sickle Cell Anemia Therapeutics by Country (2016-2021)
7.2 Europe Sickle Cell Anemia Therapeutics Market Size by Type (2016-2021)
7.3 Europe Sickle Cell Anemia Therapeutics Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Sickle Cell Anemia Therapeutics by Region (2016-2021)
8.2 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Type (2016-2021)
8.3 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Sickle Cell Anemia Therapeutics Market Forecast
10.1 Global Sickle Cell Anemia Therapeutics Forecast by Regions (2021-2026)
10.1.1 Global Sickle Cell Anemia Therapeutics Forecast by Regions (2021-2026)
10.1.2 Americas Sickle Cell Anemia Therapeutics Forecast
10.1.3 APAC Sickle Cell Anemia Therapeutics Forecast
10.1.4 Europe Sickle Cell Anemia Therapeutics Forecast
10.1.5 Middle East & Africa Sickle Cell Anemia Therapeutics Forecast
10.2 Americas Sickle Cell Anemia Therapeutics Forecast by Countries (2021-2026)
10.2.1 United States Sickle Cell Anemia Therapeutics Market Forecast
10.2.2 Canada Sickle Cell Anemia Therapeutics Market Forecast
10.2.3 Mexico Sickle Cell Anemia Therapeutics Market Forecast
10.2.4 Brazil Sickle Cell Anemia Therapeutics Market Forecast
10.3 APAC Sickle Cell Anemia Therapeutics Forecast by Region (2021-2026)
10.3.1 China Sickle Cell Anemia Therapeutics Market Forecast
10.3.2 Japan Sickle Cell Anemia Therapeutics Market Forecast
10.3.3 Korea Sickle Cell Anemia Therapeutics Market Forecast
10.3.4 Southeast Asia Sickle Cell Anemia Therapeutics Market Forecast
10.3.5 India Sickle Cell Anemia Therapeutics Market Forecast
10.3.6 Australia Sickle Cell Anemia Therapeutics Market Forecast
10.4 Europe Sickle Cell Anemia Therapeutics Forecast by Country (2021-2026)
10.4.1 Germany Sickle Cell Anemia Therapeutics Market Forecast
10.4.2 France Sickle Cell Anemia Therapeutics Market Forecast
10.4.3 UK Sickle Cell Anemia Therapeutics Market Forecast
10.4.4 Italy Sickle Cell Anemia Therapeutics Market Forecast
10.4.5 Russia Sickle Cell Anemia Therapeutics Market Forecast
10.5 Middle East & Africa Sickle Cell Anemia Therapeutics Forecast by Region (2021-2026)
10.5.1 Egypt Sickle Cell Anemia Therapeutics Market Forecast
10.5.2 South Africa Sickle Cell Anemia Therapeutics Market Forecast
10.5.3 Israel Sickle Cell Anemia Therapeutics Market Forecast
10.5.4 Turkey Sickle Cell Anemia Therapeutics Market Forecast
10.5.5 GCC Countries Sickle Cell Anemia Therapeutics Market Forecast
10.6 Global Sickle Cell Anemia Therapeutics Forecast by Type (2021-2026)
10.7 Global Sickle Cell Anemia Therapeutics Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Emmaus Medical
11.1.1 Emmaus Medical Company Information
11.1.2 Emmaus Medical Sickle Cell Anemia Therapeutics Product Offered
11.1.3 Emmaus Medical Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Emmaus Medical Main Business Overview
11.1.5 Emmaus Medical Latest Developments
11.2 Addmedica
11.2.1 Addmedica Company Information
11.2.2 Addmedica Sickle Cell Anemia Therapeutics Product Offered
11.2.3 Addmedica Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Addmedica Main Business Overview
11.2.5 Addmedica Latest Developments
11.3 Gamida Cell
11.3.1 Gamida Cell Company Information
11.3.2 Gamida Cell Sickle Cell Anemia Therapeutics Product Offered
11.3.3 Gamida Cell Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Gamida Cell Main Business Overview
11.3.5 Gamida Cell Latest Developments
11.4 GlycoMimetics
11.4.1 GlycoMimetics Company Information
11.4.2 GlycoMimetics Sickle Cell Anemia Therapeutics Product Offered
11.4.3 GlycoMimetics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 GlycoMimetics Main Business Overview
11.4.5 GlycoMimetics Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Sickle Cell Anemia Therapeutics Product Offered
11.5.3 Pfizer Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Sickle Cell Anemia Therapeutics Product Offered
11.6.3 Novartis Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Global Blood Therapeutics
11.7.1 Global Blood Therapeutics Company Information
11.7.2 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Product Offered
11.7.3 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Global Blood Therapeutics Main Business Overview
11.7.5 Global Blood Therapeutics Latest Developments
11.8 Micelle BioPharma
11.8.1 Micelle BioPharma Company Information
11.8.2 Micelle BioPharma Sickle Cell Anemia Therapeutics Product Offered
11.8.3 Micelle BioPharma Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Micelle BioPharma Main Business Overview
11.8.5 Micelle BioPharma Latest Developments
11.9 Bluebird Bio
11.9.1 Bluebird Bio Company Information
11.9.2 Bluebird Bio Sickle Cell Anemia Therapeutics Product Offered
11.9.3 Bluebird Bio Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Bluebird Bio Main Business Overview
11.9.5 Bluebird Bio Latest Developments
11.10 Prolong Pharmaceuticals
11.10.1 Prolong Pharmaceuticals Company Information
11.10.2 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Product Offered
11.10.3 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Prolong Pharmaceuticals Main Business Overview
11.10.5 Prolong Pharmaceuticals Latest Developments
11. Modus Therapeutics
11.11.1 Modus Therapeutics Company Information
11.11.2 Modus Therapeutics Sickle Cell Anemia Therapeutics Product Offered
11.11.3 Modus Therapeutics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Modus Therapeutics Main Business Overview
11.11.5 Modus Therapeutics Latest Developments
11.12 Sangamo Biosciences
11.12.1 Sangamo Biosciences Company Information
11.12.2 Sangamo Biosciences Sickle Cell Anemia Therapeutics Product Offered
11.12.3 Sangamo Biosciences Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Sangamo Biosciences Main Business Overview
11.12.5 Sangamo Biosciences Latest Developments
11.13 Bioverativ
11.13.1 Bioverativ Company Information
11.13.2 Bioverativ Sickle Cell Anemia Therapeutics Product Offered
11.13.3 Bioverativ Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Bioverativ Main Business Overview
11.13.5 Bioverativ Latest Developments
11.14 Imara
11.14.1 Imara Company Information
11.14.2 Imara Sickle Cell Anemia Therapeutics Product Offered
11.14.3 Imara Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Imara Main Business Overview
11.14.5 Imara Latest Developments
11.15 Ironwood Pharmaceuticals
11.15.1 Ironwood Pharmaceuticals Company Information
11.15.2 Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Product Offered
11.15.3 Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Ironwood Pharmaceuticals Main Business Overview
11.15.5 Ironwood Pharmaceuticals Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Sickle Cell Anemia Therapeutics Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Blood Transfusion
Table 3. Major Players of Pharmacotherapy
Table 4. Major Players of Bone Marrow Transplant
Table 5. Sickle Cell Anemia Therapeutics Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Sickle Cell Anemia Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2016-2021)
Table 8. Sickle Cell Anemia Therapeutics Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global Sickle Cell Anemia Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2016-2021)
Table 11. Global Sickle Cell Anemia Therapeutics Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Players (2019-2021E)
Table 13. Sickle Cell Anemia Therapeutics Key Players Head office and Products Offered
Table 14. Sickle Cell Anemia Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Sickle Cell Anemia Therapeutics Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Sickle Cell Anemia Therapeutics Market Size Market Share by Regions 2016-2021
Table 19. Americas Sickle Cell Anemia Therapeutics Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Sickle Cell Anemia Therapeutics Market Size Market Share by Country (2016-2021)
Table 21. Americas Sickle Cell Anemia Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2016-2021)
Table 23. Americas Sickle Cell Anemia Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2016-2021)
Table 25. APAC Sickle Cell Anemia Therapeutics Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Sickle Cell Anemia Therapeutics Market Size Market Share by Region (2016-2021)
Table 27. APAC Sickle Cell Anemia Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2016-2021)
Table 29. APAC Sickle Cell Anemia Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2016-2021)
Table 31. Europe Sickle Cell Anemia Therapeutics Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Sickle Cell Anemia Therapeutics Market Size Market Share by Country (2016-2021)
Table 33. Europe Sickle Cell Anemia Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2016-2021)
Table 35. Europe Sickle Cell Anemia Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of Sickle Cell Anemia Therapeutics
Table 44. Key Application and Potential Industries of Sickle Cell Anemia Therapeutics
Table 45. Key Challenges of Sickle Cell Anemia Therapeutics
Table 46. Key Trends of Sickle Cell Anemia Therapeutics
Table 47. Global Sickle Cell Anemia Therapeutics Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Sickle Cell Anemia Therapeutics Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Sickle Cell Anemia Therapeutics Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Sickle Cell Anemia Therapeutics Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Sickle Cell Anemia Therapeutics Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global Sickle Cell Anemia Therapeutics Market Size Market Share Forecast by Application (2021-2026)
Table 53. Emmaus Medical Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 54. Emmaus Medical Sickle Cell Anemia Therapeutics Product Offered
Table 55. Emmaus Medical Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. Emmaus Medical Main Business
Table 57. Emmaus Medical Latest Developments
Table 58. Addmedica Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 59. Addmedica Sickle Cell Anemia Therapeutics Product Offered
Table 60. Addmedica Main Business
Table 61. Addmedica Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Addmedica Latest Developments
Table 63. Gamida Cell Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 64. Gamida Cell Sickle Cell Anemia Therapeutics Product Offered
Table 65. Gamida Cell Main Business
Table 66. Gamida Cell Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. Gamida Cell Latest Developments
Table 68. GlycoMimetics Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 69. GlycoMimetics Sickle Cell Anemia Therapeutics Product Offered
Table 70. GlycoMimetics Main Business
Table 71. GlycoMimetics Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. GlycoMimetics Latest Developments
Table 73. Pfizer Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 74. Pfizer Sickle Cell Anemia Therapeutics Product Offered
Table 75. Pfizer Main Business
Table 76. Pfizer Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. Pfizer Latest Developments
Table 78. Novartis Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 79. Novartis Sickle Cell Anemia Therapeutics Product Offered
Table 80. Novartis Main Business
Table 81. Novartis Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. Novartis Latest Developments
Table 83. Global Blood Therapeutics Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 84. Global Blood Therapeutics Sickle Cell Anemia Therapeutics Product Offered
Table 85. Global Blood Therapeutics Main Business
Table 86. Global Blood Therapeutics Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 87. Global Blood Therapeutics Latest Developments
Table 88. Micelle BioPharma Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 89. Micelle BioPharma Sickle Cell Anemia Therapeutics Product Offered
Table 90. Micelle BioPharma Main Business
Table 91. Micelle BioPharma Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 92. Micelle BioPharma Latest Developments
Table 93. Bluebird Bio Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 94. Bluebird Bio Sickle Cell Anemia Therapeutics Product Offered
Table 95. Bluebird Bio Main Business
Table 96. Bluebird Bio Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 97. Bluebird Bio Latest Developments
Table 98. Prolong Pharmaceuticals Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 99. Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Product Offered
Table 100. Prolong Pharmaceuticals Main Business
Table 101. Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 102. Prolong Pharmaceuticals Latest Developments
Table 103. Modus Therapeutics Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 104. Modus Therapeutics Sickle Cell Anemia Therapeutics Product Offered
Table 105. Modus Therapeutics Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 106. Modus Therapeutics Main Business
Table 107. Modus Therapeutics Latest Developments
Table 108. Sangamo Biosciences Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 109. Sangamo Biosciences Sickle Cell Anemia Therapeutics Product Offered
Table 110. Sangamo Biosciences Main Business
Table 111. Sangamo Biosciences Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 112. Sangamo Biosciences Latest Developments
Table 113. Bioverativ Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 114. Bioverativ Sickle Cell Anemia Therapeutics Product Offered
Table 115. Bioverativ Main Business
Table 116. Bioverativ Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 117. Bioverativ Latest Developments
Table 118. Imara Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 119. Imara Sickle Cell Anemia Therapeutics Product Offered
Table 120. Imara Main Business
Table 121. Imara Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 122. Imara Latest Developments
Table 123. Ironwood Pharmaceuticals Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 124. Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Product Offered
Table 125. Ironwood Pharmaceuticals Main Business
Table 126. Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 127. Ironwood Pharmaceuticals Latest Developments
List of Figures
Figure 1. Sickle Cell Anemia Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sickle Cell Anemia Therapeutics Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Sickle Cell Anemia Therapeutics Market Size Market Share by Type in 2020
Figure 7. Sickle Cell Anemia Therapeutics in Child
Figure 8. Global Sickle Cell Anemia Therapeutics Market: Child (2016-2021) & ($ Millions)
Figure 9. Sickle Cell Anemia Therapeutics in Adult
Figure 10. Global Sickle Cell Anemia Therapeutics Market: Adult (2016-2021) & ($ Millions)
Figure 11. Global Sickle Cell Anemia Therapeutics Market Size Market Share by Application in 2020
Figure 12. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Player in 2020
Figure 13. Global Sickle Cell Anemia Therapeutics Market Size Market Share by Regions (2016-2021)
Figure 14. Americas Sickle Cell Anemia Therapeutics Market Size 2016-2021 ($ Millions)
Figure 15. APAC Sickle Cell Anemia Therapeutics Market Size 2016-2021 ($ Millions)
Figure 16. Europe Sickle Cell Anemia Therapeutics Market Size 2016-2021 ($ Millions)
Figure 17. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size 2016-2021 ($ Millions)
Figure 18. Americas Sickle Cell Anemia Therapeutics Market Size Market Share by Country in 2020
Figure 19. Americas Sickle Cell Anemia Therapeutics Market Size Market Share by Type in 2020
Figure 20. Americas Sickle Cell Anemia Therapeutics Market Size Market Share by Application in 2020
Figure 21. United States Sickle Cell Anemia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 22. Canada Sickle Cell Anemia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 23. Mexico Sickle Cell Anemia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 24. APAC Sickle Cell Anemia Therapeutics Market Size Market Share by Regions in 2020
Figure 25. APAC Sickle Cell Anemia Therapeutics Market Size Market Share by Type in 2020
Figure 26. APAC Sickle Cell Anemia Therapeutics Market Size Market Share by Application in 2020
Figure 27. China Sickle Cell Anemia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 28. Japan Sickle Cell Anemia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 29. Korea Sickle Cell Anemia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 30. Southeast Asia Sickle Cell Anemia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 31. India Sickle Cell Anemia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 32. Australia Sickle Cell Anemia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 33. Europe Sickle Cell Anemia Therapeutics Market Size Market Share by Country in 2020
Figure 34. Europe Sickle Cell Anemia Therapeutics Market Size Market Share by Type in 2020
Figure 35. Europe Sickle Cell Anemia Therapeutics Market Size Market Share by Application in 2020
Figure 36. Germany Sickle Cell Anemia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 37. France Sickle Cell Anemia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 38. UK Sickle Cell Anemia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 39. Italy Sickle Cell Anemia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 40. Russia Sickle Cell Anemia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 41. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Market Share by Region in 2020
Figure 42. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Market Share by Type in 2020
Figure 43. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Market Share by Application in 2020
Figure 44. Egypt Sickle Cell Anemia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 45. South Africa Sickle Cell Anemia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 46. Israel Sickle Cell Anemia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 47. Turkey Sickle Cell Anemia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 48. GCC Country Sickle Cell Anemia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 49. Americas Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 50. APAC Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 51. Europe Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 52. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 53. United States Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 54. Canada Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 55. Mexico Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 56. Brazil Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 57. China Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 58. Japan Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 59. Korea Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 60. Southeast Asia Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 61. India Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 62. Australia Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 63. Germany Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 64. France Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 65. UK Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 66. Italy Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 67. Russia Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 68. Spain Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 69. Egypt Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 70. South Africa Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 71. Israel Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 72. Turkey Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 73. GCC Country Sickle Cell Anemia Therapeutics Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 겸상 적혈구 빈혈 치료제 시장예측 2021년-2026년] (코드 : LPI-2201K02177) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 겸상 적혈구 빈혈 치료제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 내추럴 킬러 세포 치료법 시장예측 2021년-2026년
LPI-2201K02238 / LP Information / 2021년 12월 / 본 조사보고서는 내추럴 킬러 세포 치료법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Natural Killer Cell Therapy will have significant change from previous year. By the most conservative estimates of global Natural Killer Cell Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 201.5...

세계의 생세포 캡슐화 시장예측 2021년-2026년
LPI-2201K00095 / LP Information / 2021년 12월 / 본 조사보고서는 생세포 캡슐화의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Live Cell Encapsulation will have significant change from previous year. By the most conservative estimates of global Live Cell Encapsulation market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 mRNA 암 백신 및 치료제 시장예측 2021년-2026년
LPI-2201K02233 / LP Information / 2021년 12월 / 본 조사보고서는 mRNA 암 백신 및 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of mRNA Cancer Vaccines and Therapeutics will have significant change from previous year. By the most conservative estimates of global mRNA Cancer Vaccines and Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from...

세계의 줄기 세포 치료 시장예측 2021년-2026년
LPI-2201K02308 / LP Information / 2021년 12월 / 본 조사보고서는 줄기 세포 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Stem Cell Therapy will have significant change from previous year. By the most conservative estimates of global Stem Cell Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 387.3 million in...

세계의 mRNA 백신 및 치료제 시장예측 2021년-2026년
LPI-2201K02098 / LP Information / 2021년 12월 / 본 조사보고서는 mRNA 백신 및 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of mRNA Vaccines & Therapeutics will have significant change from previous year. By the most conservative estimates of global mRNA Vaccines & Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ million...

세계의 혈우병 A 및 B 치료제 시장예측 2021년-2026년
LPI-2201K00221 / LP Information / 2021년 12월 / 본 조사보고서는 혈우병 A 및 B 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of Hemophillia A and B Therapeutics Materials will have significant change from previous year. By the most conservative estimates of global Hemophillia A and B Therapeutics Materials market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in...

세계의 표적 단백질 분해 치료제 시장예측 2021년-2026년
LPI-2201K02312 / LP Information / 2021년 12월 / 본 조사보고서는 표적 단백질 분해 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Targeted-protein Degradation Therapeutics will have significant change from previous year. By the most conservative estimates of global Targeted-protein Degradation Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...